Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Connor

Showing results (241-250 of 357) with videos related to

Pageof 36
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Role of Kupffer cells in reperfusion injury in fat-loaded livers from ethanol-treated ratsZ Zhong, H D Connor, R P Mason, et al.
Journal of Environmental Management|July 13, 2015
Real options analysis for land use management: Methods, application, and implications for policyCourtney M Regan, Brett A Bryan, Jeffery D Connor, et al.
Neurosurgery|November 1, 1980
Prospective randomized study of therapy in cerebrospinal fluid shunt infectionH E James, J W Walsh, H D Wilson, et al.
Therapeutic Drug Monitoring|January 1, 1989
Controlled release infusion kinetics of tobramycinJ R Lane, W E Murray, N L Willenborg, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Disposition of intravenous radioactive acyclovirP de Miranda, S S Good, O L Laskin, et al.
The American Journal of Psychiatry|June 3, 2006
Binge drinking during pregnancy as a predictor of psychiatric disorders on the Structured Clinical Interview for DSM-IV in young adult offspringHelen M Barr, Fred L Bookstein, Kieran D O'Malley, et al.
Pediatric Research|June 1, 1972
The oxidation of glycine and propionic acid in propionic acidemia with ketotic hyperglycinemiaT Ando, W L Nyhan, J D Connor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1978
Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitorH J Doller, J D Connor, D R Lock, et al.
The American Journal of Medicine|July 20, 1982
Metabolic fate of radioactive acyclovir in humansP de Miranda, S S Good, H C Krasny, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Pageof 36

Showing results (241-250 of 357) with videos related to

Sort By:
Pageof 36
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Role of Kupffer cells in reperfusion injury in fat-loaded livers from ethanol-treated ratsZ Zhong, H D Connor, R P Mason, et al.
Journal of Environmental Management|July 13, 2015
Real options analysis for land use management: Methods, application, and implications for policyCourtney M Regan, Brett A Bryan, Jeffery D Connor, et al.
Neurosurgery|November 1, 1980
Prospective randomized study of therapy in cerebrospinal fluid shunt infectionH E James, J W Walsh, H D Wilson, et al.
Therapeutic Drug Monitoring|January 1, 1989
Controlled release infusion kinetics of tobramycinJ R Lane, W E Murray, N L Willenborg, et al.
Clinical Pharmacology and Therapeutics|November 1, 1981
Disposition of intravenous radioactive acyclovirP de Miranda, S S Good, O L Laskin, et al.
The American Journal of Psychiatry|June 3, 2006
Binge drinking during pregnancy as a predictor of psychiatric disorders on the Structured Clinical Interview for DSM-IV in young adult offspringHelen M Barr, Fred L Bookstein, Kieran D O'Malley, et al.
Pediatric Research|June 1, 1972
The oxidation of glycine and propionic acid in propionic acidemia with ketotic hyperglycinemiaT Ando, W L Nyhan, J D Connor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1978
Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitorH J Doller, J D Connor, D R Lock, et al.
The American Journal of Medicine|July 20, 1982
Metabolic fate of radioactive acyclovir in humansP de Miranda, S S Good, H C Krasny, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndromeR B Roberts, O L Laskin, J Laurence, et al.
Pageof 36